Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • JAK 1/2 inhibition following bone marrow transplantation mitigates Cd11b + /GR1+ mediated low-grade glioma neoangiogenesis
    Meeting Abstract

    Rajappa, P.; Huang, Y. J.; Vartanian, E.; Pisapia, D.; Lyden, D.; Bromberg, J.; Greenfield, J.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • ID2/KDR drives formation of pro-malignant myeloid derived suppressor cells in glioma
    Meeting Abstract

    Huang, Y. J.; Rajappa, P.; Bromberg, J.; Lyden, D.; Greenfield, J.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Ofatumumab-bendamustine as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk adapted design with comprehensive geriatric assessment
    Meeting Abstract

    Casulo, C.; Iannotta, A.; Walkley, J.; Moskowitz, C. H.; Moskowitz, A. J.; Drullinsky, P.; Zelenetz, A. D.; Hamlin, P.
    Blood (2014)

    Fulltext@MSK | Save
  • A phase III randomized, double-blind, trial comparing sorafenib plus capecitabine versus placebo plus capecitabine in the treatment of locally advanced or metastatic HER2-negative breast cancer (resilience)
    Meeting Abstract

    Baselga, J.; Zamagni, C.; Gomez, P.; Bermejo, B.; Nagai, S.; Melichar, B.; Chan, A.; Mangel, L.; Bergh, J.; Costa, F. P.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2-advanced/metastatic breast cancer: Results from a Phase Ib clinical trial
    Meeting Abstract

    Bardia, A.; Chavez-MacGregor, C.; Modi, S.; Campone, M.; Ma, B.; Kittaneh, M.; Dirix, L.; Motta, M.; Zhang, V.; Bhansali, S.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research
    Journal Article

    Moossdorff, M.; van Roozendaal, L. M.; Strobbe, L. J. A.; Aebi, S.; Cameron, D. A.; Dixon, J. M.; Giuliano, A. E.; Haffty, B. G.; Hickey, B. E.; Hudis, C. A.; more...
    JNCI: Journal of the National Cancer Institute (2014)

    Fulltext@MSK | Save
  • Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance)
    Journal Article

    Klepin, H. D.; Pitcher, B. N.; Ballman, K. V.; Kornblith, A. B.; Hurria, A.; Winer, E. P.; Hudis, C.; Cohen, H. J.; Muss, H. B.; Kimmick, G. G.
    Journal of Oncology Practice (2014)

    Fulltext@MSK | Save
  • Combination of RAF and MEK inhibition for the treatment of BRAF-mutated melanoma: Feedback is not encouraged
    Journal Article

    Chapman, P. B.; Solit, D. B.; Rosen, N.
    Cancer Cell (2014)

    Fulltext@MSK | Save